Zobrazeno 1 - 10
of 178
pro vyhledávání: '"Luisa De-Castro"'
Autor:
Mario Álvarez Salas, Pietro Sica, Maja Rydgård, Tomas Javier Sitzmann, Jared Onyango Nyang’au, Jihane El Mahdi, Egor Moshkin, Hellen Luisa de Castro e Silva, Stamatis Chrysanthopoulos, Clara Kopp, Khan Wali, Yusra Zireeni, Aslihan Ural-Janssen, Samaya El Hajj Hassan, Lelenda Florent Kebalo, David Chadwick, Lars Stoumann Jensen
Publikováno v:
Frontiers in Sustainable Food Systems, Vol 8 (2024)
To meet global food demands sustainably, it is necessary to safeguard finite natural resources and reduce harmful emissions to the environment. Nutrients in biowastes are often not managed appropriately. Instead, they can be recovered, recycled into
Externí odkaz:
https://doaj.org/article/399b4914ba414361be7fbdf0615e81e8
Autor:
Goretti Hernández, Enrique Quintero, Dalia Morales-Arraez, Guillermo García Rayado, Gonzalo Hijos-Mallada, Nereida Fernández-Fernández, Luisa de Castro-Parga, María Victoria Álvarez-Sánchez, Carolina Olano, Daniel Rodríguez-Alcalde, Carla Amaral-González, Inmaculada Alonso-Abreu, David Nicolás-Pérez, Marta Carrillo-Palau, Enrique González-Dávila, Antonio Z. Gimeno-García
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
ObjectiveIn patients with iron deficiency anaemia (IDA), the diagnostic yield of gastroscopy and colonoscopy (bidirectional endoscopy) in detecting neoplastic lesions is low. This study aimed to develop and validate a faecal immunochemical test (FIT)
Externí odkaz:
https://doaj.org/article/e91fc591bd7343b896bab1d8a7c807ed
Autor:
Luisa de Castro e Silva, Hellen, Ghysels, Stef, Robles-Aguilar, Ana A., Akyol, Çağrı, Ronsse, Frederik, Meers, Erik
Publikováno v:
In Chemical Engineering Journal 15 September 2024 496
Autor:
Luisa de Castro e Silva, Hellen, Robles-Aguilar, Ana A., Akyol, Çağrı, Willems, Bernard, Meers, Erik
Publikováno v:
In Bioresource Technology June 2024 402
Autor:
Celia Gómez-Labrador, Elena Ricart, Marisa Iborra, Eva Iglesias, María Dolores Martín-Arranz, Luisa de Castro, Ruth De Francisco, Francisco Javier García-Alonso, Ana Sanahuja, Carla J. Gargallo-Puyuelo, Francisco Mesonero, María José Casanova, Míriam Mañosa, Montserrat Rivero, Marta Calvo, Mónica Sierra-Ausin, Carlos González-Muñoza, Xavier Calvet, Santiago García-López, Jordi Guardiola, Lara Arias García, Lucía Márquez-Mosquera, Ana Gutiérrez, Yamile Zabana, Mercè Navarro-Llavat, Rufo Lorente Poyatos, Marta Piqueras, Leyanira Torrealba, Fernando Bermejo, Ángel Ponferrada-Díaz, José L. Pérez-Calle, Manuel Barreiro-de Acosta, Coral Tejido, José Luis Cabriada, Ignacio Marín-Jiménez, Óscar Roncero, Yolanda Ber, Luis Fernández-Salazar, Blau Camps Aler, Alfredo J. Lucendo, Jordina Llaó, Luis Bujanda, Carmen Muñoz Villafranca, Eugeni Domènech, María Chaparro, Javier P. Gisbert
Publikováno v:
Pharmaceutics, Vol 16, Iss 5, p 629 (2024)
Markers that allow for the selection of tailored treatments for individual patients with inflammatory bowel diseases (IBD) are yet to be identified. Our aim was to describe trends in real-life treatment usage. For this purpose, patients from the ENEI
Externí odkaz:
https://doaj.org/article/07a5bfcf65344f8daf0648e08c7a639c
Autor:
Margalida Calafat, Paola Torres, Joan Tosca-Cuquerella, Rubén Sánchez-Aldehuelo, Montserrat Rivero, Marisa Iborra, María González-Vivo, Isabel Vera, Luisa de Castro, Luis Bujanda, Manuel Barreiro-de Acosta, Carlos González-Muñoza, Xavier Calvet, José Manuel Benítez, Mónica Llorente-Barrio, Gerard Surís, Fiorella Cañete, Lara Arias-García, David Monfort, Andrés Castaño-García, Francisco Javier Garcia-Alonso, José M. Huguet, Ignacio Marín-Jímenez, Rufo Lorente, Albert Martín-Cardona, Juan Ángel Ferrer, Patricia Camo, Javier P. Gisbert, Ramón Pajares, Fernando Gomollón, Jesús Castro-Poceiro, Jair Morales-Alvarado, Jordina Llaó, Andrés Rodríguez, Cristina Rodríguez, Pablo Pérez-Galindo, Mercè Navarro, Nuria Jiménez-García, Marta Carrillo-Palau, Isabel Blázquez-Gómez, Eva Sesé, Pedro Almela, Patricia Ramírez de la Piscina, Carlos Taxonera, Iago Rodríguez-Lago, Lidia Cabrinety, Milagros Vela, Miguel Mínguez, Francisco Mesonero, María José García, Mariam Aguas, Lucía Márquez, Marisol Silva Porto, Juan R. Pineda, Koldo García-Etxebarría, Federico Bertoletti, Eduard Brunet, Míriam Mañosa, Eugeni Domènech
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 17 (2024)
Background: Infliximab seems to be the most efficacious of the three available anti-TNF agents for ulcerative colitis (UC) but little is known when it is used as the second anti-TNF. Objectives: To compare the clinical and treatment outcomes of a sec
Externí odkaz:
https://doaj.org/article/775611ead93843fdbf2cc167c6af141b
Autor:
Luisa de Castro e Silva, Hellen, Sigurnjak, Ivona, Robles-Aguilar, Ana, Adriaens, Anne, Meers, Erik
Publikováno v:
In Waste Management 1 August 2023 168:334-343
Autor:
Natalia González-López, Enrique Quintero, Antonio Z Gimeno-Garcia, Luis Bujanda, Jesús Banales, Joaquin Cubiella, María Salve-Bouzo, Jesus Miguel Herrero-Rivas, Estela Cid-Delgado, Victoria Alvarez-Sanchez, Alejandro Ledo-Rodríguez, Maria Luisa de-Castro-Parga, Romina Fernández-Poceiro, Luciano Sanromán-Álvarez, Jose Santiago-Garcia, Alberto Herreros-de-Tejada, Teresa Ocaña-Bombardo, Francesc Balaguer, María Rodríguez-Soler, Rodrigo Jover, Marta Ponce, Cristina Alvarez-Urturi, Xavier Bessa, Maria-Pilar Roncales, Federico Sopeña, Angel Lanas, David Nicolás-Pérez, Zaida Adrián-de-Ganzo, Marta Carrillo-Palau, Enrique González-Dávila, Oncology Group of Asociación Española de Gastroenterología
Publikováno v:
PLoS Medicine, Vol 20, Iss 10, p e1004298 (2023)
BackgroundColonoscopy screening is underused by first-degree relatives (FDRs) of patients with non-syndromic colorectal cancer (CRC) with screening completion rates below 50%. Studies conducted in FDR referred for screening suggest that fecal immunoc
Externí odkaz:
https://doaj.org/article/4dadedc544ec47348ee6a87bd36f8a29
Autor:
Ana Gutiérrez, Pedro Zapater, Elena Ricart, María González-Vivó, Jordi Gordillo, David Olivares, Isabel Vera, Míriam Mañosa, Javier P. Gisbert, Mariam Aguas, Eugenia Sánchez-Rodríguez, Maia Bosca-Watts, Viviana Laredo, Blau Camps, Ignacio Marín-Jiménez, Yamile Zabana, María Dolores Martín-Arranz, Roser Muñoz, Mercè Navarro, Eva Sierra, Lucía Madero, Milagros Vela, José Lázaro Pérez-Calle, Empar Sainz, Xavier Calvet, Lara Arias, Victor Morales, Fernando Bermejo, Luis Fernández-Salazar, Manuel Van Domselaar, Luisa De Castro, Cristina Rodríguez, Carmen Muñoz-Villafranca, Rufo Lorente, Montserrat Rivero, Eva Iglesias, Belén Herreros, David Busquets, Joan Riera, María Pilar Martínez-Montiel, Marta Roldón, Oscar Roncero, Esther Hinojosa, Mónica Sierra, Jesús Barrio, Ruth De Francisco, José Huguet, Olga Merino, Daniel Carpio, Daniel Ginard, Fernando Muñoz, Marta Piqueras, Pedro Almela, Federico Argüelles-Arias, Guillermo Alcaín, Luis Bujanda, Noemí Manceñido, Alfredo J. Lucendo, Pilar Varela, Iago Rodríguez-Lago, Laura Ramos, Laura Sempere, Eva Sesé, Manuel Barreiro-de Acosta, Eugeni Domènech, Rubén Francés
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
BackgroundPrevious studies comparing immigrant ethnic groups and native patients with IBD have yielded clinical and phenotypic differences. To date, no study has focused on the immigrant IBD population in Spain.MethodsProspective, observational, mult
Externí odkaz:
https://doaj.org/article/d35e6ff2cdf74ae5a842b5e0dd987f1c
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.